Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Operational Research for Cryptococcal Antigen Screening to Improve ART Survival

NCT01535469 is registered in ClinicalTrials.gov with University of Minnesota as lead sponsor.

NCT NCT01535469
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01535469 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Operational Research for Cryptococcal Antigen Screening to Improve ART Survival
Lead sponsor
University of Minnesota
Phase
Phase 4
Overall status
Completed
Start date
July 1, 2012
Completion date
June 30, 2015
Enrollment
3,049 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

cryptococcal meningitis, cryptococcosis, cryptococcus neoformans